VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.
about
Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assaysPrenatal diagnosis and prevention of toxoplasmosis in pregnant women in Northern Vietnam: study protocolEuropean multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.Prevalence of pregnancy-relevant infections in a rural setting of Ghana.Detection of IgM and IgG anti-Toxoplasma antibodies in renal transplant recipients using ELFA, ELISA and ISAGA methods: comparison of pre- and post-transplantation status.Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adultsIgG avidity antibodies against Toxoplasma gondii in high risk females of reproductive age group in India.The necessity of confirmatory testing in serodiagnosis of toxoplasmosis in iran.Seroepidemiological analysis of toxoplasmosis in college students.Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancyReliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant womenIdentification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results.Toxoplasmosis - An update.Twenty-six circulating antigens and two novel diagnostic candidate molecules identified in the serum of canines with experimental acute toxoplasmosis.Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newbornsManagement of Toxoplasma gondii infection during pregnancy.Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women.Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodiesToxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studiesEvaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy.Detection of immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections.Parasitic infections and myositis.Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil.Toxoplasma-IgM and IgG-avidity in single samples from areas with a high infection rate can determine the risk of mother-to-child transmission.Seroprevalence of Toxoplasma gondii in women who have aborted in comparison with the women with normal delivery in Ahvaz, southwest of Iran
P2860
Q24645130-3AD02B91-3442-456F-BBEE-B79CDA51BF2AQ30376785-B41CCB8B-A83D-4EA2-9CAD-2733E6EA8BBEQ33753178-665F0617-9533-4FDB-89B9-CDD803AA2CBAQ33767981-2E782C4C-70EA-47A1-84CA-11B190B69F45Q33873555-490BA8EF-73E0-493A-A0E0-1D90E950947CQ33884948-4B04E70A-C0FC-4EF8-9E34-C242650B3417Q34411023-27BC673E-0A58-4D6D-A7E9-DF38AA4FB758Q34700187-FC964681-D627-434A-AE70-2F488B966966Q34941707-876FCE80-7BD6-4EDF-BFC6-A3AD8CBC6206Q34948181-30A32E11-3CCA-40DA-AE35-E5DFE63545F5Q35523413-6ECBB540-09EA-4E95-B09A-434139267B3EQ35542471-BAE17829-4EC1-4022-BCFA-F235526CF98AQ36378655-25990714-E113-43C4-AB47-D07F6B917F99Q36671583-9743A3F4-0DAD-43EF-A777-70107DBF0C28Q37054900-DD863FCA-D2D4-4E0A-B81E-E615B2C5562EQ37124736-3CCB5788-CEFE-43C2-B686-44E0A7ECD70EQ37215176-1A77CE32-1252-483D-BA15-98AA88CF3645Q37360196-CE03F1EB-24D1-4D84-8439-01A4A6825C72Q37374671-8071DFB1-BC32-4C3A-958E-9494C8F0A486Q37469581-5AAE95BB-4F9D-4D9F-BAF2-0A096DFE519CQ37576269-E3BA9D4A-1683-49C9-A377-F41C46BB0217Q37702723-4850BB92-BBFE-44B8-B9BD-7120EA12B0B0Q37924643-C49F3CD3-FC66-42B8-9DA4-45017F6F0186Q44899127-66C45E51-3E9B-4E8D-A8D4-CFF606C479CFQ47857201-F1C31984-1E3D-4067-A30E-411E70CB5C45Q59121321-E1A7D767-F9C7-47A6-AC43-2063FC470E5F
P2860
VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
VIDAS test for avidity of Toxo ...... ory testing of pregnant women.
@ast
VIDAS test for avidity of Toxo ...... ory testing of pregnant women.
@en
type
label
VIDAS test for avidity of Toxo ...... ory testing of pregnant women.
@ast
VIDAS test for avidity of Toxo ...... ory testing of pregnant women.
@en
prefLabel
VIDAS test for avidity of Toxo ...... ory testing of pregnant women.
@ast
VIDAS test for avidity of Toxo ...... ory testing of pregnant women.
@en
P2093
P2860
P1476
VIDAS test for avidity of Toxo ...... ory testing of pregnant women.
@en
P2093
Cynthia Press
Jack S Remington
Jose G Montoya
Oliver Liesenfeld
Sandra Kinney
P2860
P304
P356
10.1128/JCM.40.7.2504-2508.2002
P407
P577
2002-07-01T00:00:00Z